P043 Bortezomib plus dexametasone in relapsed and refractory multiple myeloma: standard, weekly and retreatment modalities

Autor:	A. Domínguez, M. Anguita, A. Alcalá, M.M. Nieto, C. Santis, J.M. Ramírez, S. Esteban, Juan Antonio López, P. González, I. Muro, M.L. Escudero, S. Durán
Rok vydání:	2007
Předmět:	Oncology Cancer Research medicine.medical_specialty Modalities Bortezomib business.industry Internal medicine medicine Refractory Multiple Myeloma Hematology business medicine.drug
Zdroj:	Leukemia Research. 31:S84
ISSN:	0145-2126
DOI:	10.1016/s0145-2126(07)70391-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9d307d220c8e9808938d31115758a665 https://doi.org/10.1016/s0145-2126(07)70391-0 Zobrazit plný text záznamu Full Text from ScienceDirect